Phase I/II trial of PAT-SM6 in combination with carfilzomib in patients with relapsed or refractory multiple myeloma

Trial Profile

Phase I/II trial of PAT-SM6 in combination with carfilzomib in patients with relapsed or refractory multiple myeloma

Planning
Phase of Trial: Phase I/II

Latest Information Update: 13 Sep 2016

At a glance

  • Drugs PAT SM6 (Primary) ; Carfilzomib; Dexamethasone
  • Indications Multiple myeloma
  • Focus Therapeutic Use
  • Sponsors Onyx Pharmaceuticals
  • Most Recent Events

    • 13 Sep 2016 According to a Patrys media release, this trial continues to be on hold.
    • 11 Jun 2015 According to Patrys media release, this trial is still on hold due to low manufacturing yield.
    • 07 Nov 2014 Planned initiation date changed from 1 Dec 2014 to 1 Jun 2015, according to a Patrys media release.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top